Condition
Hypogonadotropic Hypogonadism
Hypogonadotropic hypogonadism is a condition in which the pituitary gland releases too little LH and FSH, so the testes or ovaries make too little sex hormone. Research has focused on gonadorelin, a diagnostic test rather than a supplement, and the evidence is strong that it shows how the pituitary responds by measuring LH and FSH. Before puberty it could not separate this condition from constitutionally delayed puberty, but afterward it was useful.
Sources: PMID 15554892
- Updated
- How we grade
- 36 studies cited
- Supplements studied
- 0
- Medicines and peptides
- 1
- Graded outcomes
- 4
Prescription medicines and peptides studied, for context
Key findings
- Puberty InductionImproves (the measure goes up)
- Spermatogenesis InductionImproves (the measure goes up)
- Diagnostic AccuracyImproves (the measure goes up)
Shop the evidence-backed picks
Support alongside medical care. These supplements are not a treatment for Hypogonadotropic Hypogonadism. If you are being treated for it, talk to your clinician before adding one: supplements can interact with medicines.
The collection holds the supplements we grade A or B for its theme, in third-party tested products where the catalog has them. It opens in our Fullscript store. You can look through it without signing in; Fullscript asks for a free account to order.
We earn from purchases made in our Fullscript store, and links to Fullscript, iHerb or Thorne carry our referral, so we may earn a commission at no extra cost to you. Grades come from the research and never change based on what we earn. Full disclosure
Studies cited
36 studies from PubMed
- Effects of gonadorelin on gonadotropin expression, plasma sex steroid concentrations and ovarian follicle dynamics in mature tambaqui (Colossoma macropomum).
- A biomimetic enzyme-linked immunosorbent assay (BELISA) for the analysis of gonadorelin by using molecularly imprinted polymer-coated microplates.
- The safety of neoadjuvant hormonal treatment in infants with cryptorchidism.
- Gonadotropin Treatment for the Male Hypogonadotropic Hypogonadism
- Gonadotropin-releasing hormone stimulation test and diagnostic cutoff in precocious puberty
- The Pulsatile Gonadorelin Pump Induces Earlier Spermatogenesis Than Cyclical Gonadotropin Therapy in Congenital Hypogonadotropic Hypogonadism Men
- Impact of phase of the estrous cycle and season on LH surge profile and fertility in dairy cows treated with different GnRH analogs (gonadorelin vs. buserelin).
- Role of Gonadotropin-releasing Hormone Stimulation Test in Diagnosing Gonadotropin Deficiency in Both Males and Females with Delayed Puberty
- Effect of gonadorelin, lecirelin, and buserelin on LH surge, ovulation, and progesterone in cattle.
- Effect of different gonadorelin (GnRH) products used for the first or resynchronized timed artificial insemination on pregnancy rates in postpartum dairy cows.
- Raloxifene and antiestrogenic gonadorelin inhibits intestinal tumorigenesis by modulating immune cells and decreasing stem-like cells.
- [Micropump infusion of gonadorelin in the treatment of hypogonadotropic hypogonadism in patients with pituitary stalk interruption syndrome: cases analysis and literature review].
- Comparison of gonadorelin products in lactating dairy cows: efficacy based on induction of ovulation of an accessory follicle and circulating luteinizing hormone profiles.
- [Side effects of treatment with the long-acting gonadorelin agonist triptorelin in a case of paraphilia].
- [Ovulation inducing drugs].
- The effect of different doses of gonadorelin on ovarian follicle dynamics in river buffalo (Bubalus bubalis).
- The effects of 3 gonadorelin products on luteinizing hormone release, ovulation, and follicular wave emergence in cattle.
- If gonadotropin-releasing hormone plus growth hormone (GH) really improves growth outcomes in short non-GH-deficient children, then what?
- [Research progress in immune regulation of gonadorelin].
- Gonadorelin-induced testosterone release: a biological assay for quality assurance of gonadorelin in veterinary medicine.
- Induction of spermatogenesis with pulsatile gonadotropin-releasing hormone in men with hypogonadotropic hypogonadism
- Response to gonadotrophin-releasing hormone by the intact male dog: serum testosterone, luteinizing hormone and follicle-stimulating hormone.
- Clinical applications of gonadotropin releasing hormone analogues
- GnRH analogues in reproductive medicine.
- Gonadorelin for induction of ovulation.
- [Treatment of cancer of the prostate. Role of gonadorelin analogs].
- Immunoglobulin-mediated hypersensitivity in response to long-term treatment with gonadorelin hydrochloride (Factrel) in a female patient.
- Application of gonadotropin releasing hormone in hypogonadotropic hypogonadism--diagnostic and therapeutic aspects
- The GnRH test in the diagnosis of hypogonadotropic hypogonadism
- Pulsatile gonadotropin-releasing hormone therapy in male patients with hypogonadotropic hypogonadism
- The use of pulsatile gonadotropin-releasing hormone (GnRH) for the induction of puberty and fertility in patients with GnRH deficiency
- Ovulation induction with pulsatile intravenous GnRH.
- [Treatment of advanced prostatic cancer with a gonadorelin agonist, dTrp6 LHRH. 41 cases].
- Long-term pulsatile LHRH treatment in male patients with hypogonadotropic hypogonadism
- The International Reference Preparation of Gonadorelin for Bioassay: a comparison with different preparations of synthetic luteinizing hormone releasing hormone using physicochemical methods of analysis, different bioassays and immunoassay.
- Induction of puberty with pulsatile gonadotropin-releasing hormone